Gowling WLG advised Nanexa on the deal.The transaction involved a material transfer and feasibility study agreement with global pharmaceutical company Novo Nordisk A/S. The deal facilitates the…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
